Safety, metabolic and psychological outcomes of Medtronic MiniMed 780G™ in children, adolescents and young adults: a systematic review
S Passanisi, F Lombardo, C Mameli, B Bombaci… - Diabetes Therapy, 2024 - Springer
Abstract The MiniMed™ 780G is a second-generation automated insulin delivery system
that implements a modified proportional–integral–derivative algorithm with some features of …
that implements a modified proportional–integral–derivative algorithm with some features of …
Emerging technologies and therapeutics for type 1 diabetes
HK Akturk, AM McKee - Endocrinology and Metabolism Clinics, 2024 - endo.theclinics.com
Advancements in diabetes technologies in recent years changed the landscape of type 1
diabetes (T1D) management. 1 Increasing the use of continuous glucose monitors (CGM) …
diabetes (T1D) management. 1 Increasing the use of continuous glucose monitors (CGM) …
Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics
Z Henry, S Villar Fimbel, N Bendelac… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim To investigate glycaemic outcomes in youths and adults with type 1 diabetes with either
MiniMed™ 780G or Tandem t: slim X2™ control‐IQ automated insulin delivery (AID) systems …
MiniMed™ 780G or Tandem t: slim X2™ control‐IQ automated insulin delivery (AID) systems …
Glycemia risk index as a novel metric to evaluate the safety of glycemic control in children and adolescents with type 1 diabetes: an observational, multicenter, real-life …
C Piona, M Marigliano, C Roncarà… - Diabetes Technology …, 2023 - liebertpub.com
Glycemia risk index (GRI) is a novel composite metric for the evaluation of the safety of
glycemic management and control. The aim of this study was to evaluate GRI and its …
glycemic management and control. The aim of this study was to evaluate GRI and its …
Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes
C Pihoker, DI Shulman, GP Forlenza… - Diabetes Technology …, 2023 - liebertpub.com
Background: During MiniMed™ advanced hybrid closed-loop (AHCL) use by adolescents
and adults in the pivotal trial, glycated hemoglobin (A1C) was significantly reduced, time …
and adults in the pivotal trial, glycated hemoglobin (A1C) was significantly reduced, time …
Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study
A Santova, L Plachy, V Neuman, M Pavlikova… - Frontiers in …, 2023 - frontiersin.org
Objective To compare parameters of glycemic control among three types of hybrid closed
loop (HCL) systems in children with T1D (CwD) using population-wide data from the …
loop (HCL) systems in children with T1D (CwD) using population-wide data from the …
Aiming for the best glycemic control beyond time in range: time in tight range as a new continuous glucose monitoring metric in children and adolescents with type 1 …
S Passanisi, C Piona, G Salzano… - Diabetes Technology …, 2024 - liebertpub.com
Introduction: To evaluate time in tight range (TITR) 70–140 mg/dL (3.9–7.8 mmol/L), its
correlation with standard continuous glucose monitoring (CGM) metrics and the clinical …
correlation with standard continuous glucose monitoring (CGM) metrics and the clinical …
The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed …
J Castañeda, A Arrieta… - Diabetes, Obesity and …, 2023 - Wiley Online Library
Abstract Aim Use of the MiniMed 780G system (MM780G) can result in a reduction in mean
and standard deviation (SD) of sensor glucose (SG) values. We assessed the significance of …
and standard deviation (SD) of sensor glucose (SG) values. We assessed the significance of …
Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus …
SN Edd, J Castañeda, P Choudhary… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aims To reassess the 6‐month efficacy and to assess the 12‐month sustained efficacy of the
MiniMed™ 780G advanced hybrid closed‐loop automated insulin delivery (AID) system …
MiniMed™ 780G advanced hybrid closed‐loop automated insulin delivery (AID) system …
Real-world performance of first-versus second-generation automated insulin delivery systems on a pediatric population with type 1 diabetes: A one-year observational …
B Bombaci, S Passanisi, M Valenzise… - Journal of Diabetes …, 2023 - journals.sagepub.com
Background: The aim of this single-center observational study was to assess the real-world
performance of first-and second-generation automated insulin delivery (AID) systems in a …
performance of first-and second-generation automated insulin delivery (AID) systems in a …